Invezz

Piper Sandler Companies (PIPR)

NYSE Market Closed

Piper Sandler Companies is an investment bank and institutional securities firm serving corporate clients, financial sponsors, public sector issuers, nonprofit organizations, and institutional investors. Headquartered in the United States with an international reach, the firm provides advice and execution across mergers and acquisitions, capital raising, public finance, equity and fixed income markets, research, brokerage, and alternative asset management.

The company is best known for middle-market investment banking, where it advises companies and private equity groups on strategic transactions. Its advisory business is a major revenue driver and includes M&A, restructuring, fairness opinions, and other corporate finance assignments. Piper Sandler also helps clients access capital through equity and debt offerings, with sector expertise across areas such as healthcare, financial services, consumer, energy, technology, and diversified industrials.

Beyond corporate investment banking, Piper Sandler has a significant public finance franchise that works with state and local governments, school districts, healthcare systems, and other public entities. Its institutional securities operations provide sales, trading, and research services to asset managers, banks, insurance companies, hedge funds, and other professional investors. The firm’s research platform covers equities and macro themes, supporting both investor clients and capital markets activity.

PIPR is exposed to cycles in dealmaking, market volatility, interest rates, investor risk appetite, and new issuance activity. When mergers, acquisitions, IPOs, and debt financings are active, fee opportunities generally improve; when markets weaken, advisory and underwriting volumes can slow. The company’s appeal lies in its specialized sector knowledge, broad institutional relationships, and diversified mix of advisory, financing, public finance, brokerage, and asset management services.

72.14 USD
72.22 USD
−0.20 (-0.28%)
After-hours

Last updated

Market Cap
$5,248,063,136
P/E
18.63
P/FCF
11.01
P/S
2.6
Enterprise Value
$4,918,629,136
Sector
Financials
Industry
Security Brokers, Dealers, and Flotation Companies
Address
350 NORTH 5TH STREET, SUITE 1000, MINNEAPOLIS, MN, 55401
investing.com

Tesla’s Earnings Loom With Almost No Room for Error

Jan 15, 2026, 14:32 PM
globenewswire.com

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

Dec 02, 2025, 22:11 PM
globenewswire.com

Amneal to Participate in Upcoming Investor Conferences

Dec 02, 2025, 08:00 AM
globenewswire.com

Information relating to the stabilization activities carried out in the context of its recent offering

Nov 24, 2025, 16:00 PM
globenewswire.com

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Nov 20, 2025, 07:00 AM
globenewswire.com

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 07:00 AM
globenewswire.com

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

Nov 13, 2025, 23:07 PM
globenewswire.com

BillionToOne Announces Pricing of Upsized Initial Public Offering

Nov 05, 2025, 21:53 PM
globenewswire.com

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

Oct 16, 2025, 23:45 PM
globenewswire.com

Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)

Oct 14, 2025, 16:00 PM
globenewswire.com

Inventiva Announces the Implementation of a New ATM Program

Oct 14, 2025, 16:00 PM
globenewswire.com

Esperion Announces Pricing of Public Offering of Common Stock

Oct 07, 2025, 21:29 PM
globenewswire.com

LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering

Sep 10, 2025, 21:03 PM
globenewswire.com

Great Elm Capital Corp. Prices Public Offering of $50 Million of 7.75% Notes Due 2030

Sep 04, 2025, 17:36 PM
globenewswire.com

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

Aug 12, 2025, 22:28 PM
Market Cap
$5,248,063,136
Enterprise Value
$4,918,629,136
P/E
18.63
P/B
3.91
P/S
2.6
EV / EBITDA
11.2
EV / Sales
2.43
EPS
4.17
Dividend Yield
2.76%
P/FCF
11.01
P/CF
10.45
Free Cash Flow
$476,463,000
ROE
20.99%
ROA
13.22%
Debt / Equity
0.01
Current Ratio
2.67
Quick Ratio
2.67
Cash
1.4
Avg Volume
$539,323
Fundamentals Snapshot Price
77.66

Income Statement

Line Item 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Revenue 475.15M 666.99M 462.37M 393.88M 347.92M
Gross profit 456.39M 635.18M 461.55M 392.08M 346.64M
Operating income 88.67M 189.81M 107.43M 48.92M 29.43M
EBITDA 95.46M 197.76M 114.24M 55.15M 35.72M
Net income 65.24M 113.97M 60.27M 42.18M 64.92M
Basic EPS
Diluted EPS

Balance Sheet

Line Item 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Total assets 2.13B 2.59B 2.22B 1.96B 1.82B
Total liabilities 572.2M 1.01B 756.66M 559.73M 442.39M
Total equity 1.34B 1.37B 1.28B 1.23B 1.21B
Cash & equivalents 344.43M 809.42M 114M 123.32M 126.08M
Current assets 765.71M 924.94M 711.57M 426.09M 318.12M
Current liabilities 57.15M 40.66M 101.76M 21.13M 59.7M

Cash Flow

Line Item 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Operating cash flow -314.73M 847.3M 31.91M 32.14M -207.23M
Investing cash flow 20.87M -118.35M -14.97M -14.22M -11.15M
Financing cash flow -170.09M -33.73M -25.23M -22.67M -139.56M
Change in cash -464.98M 695.42M -9.33M -2.76M -356.75M
  • EODHD filings mapper does not expose edgar_index parity from the SDK/API yet.
  • EODHD filings mapper does not expose ten_k_section parity from the SDK/API yet.
  • EODHD filings mapper does not expose eight_k_text parity from the SDK/API yet.
  • EODHD filings mapper does not expose form_3 parity from the SDK/API yet.
Kind Filing Date Link
form 4 Form 4 — Debbra L Schoneman View Filing
form 4 Form 4 — Chad R Abraham View Filing
form 4 Form 4 — Chad R Abraham View Filing
form 4 Form 4 — Katherine Patricia Clune View Filing
form 4 Form 4 — Debbra L Schoneman View Filing
form 4 Form 4 — John W Geelan View Filing
form 4 Form 4 — Chad R Abraham View Filing
form 4 Form 4 — Chad R Abraham View Filing
form 4 Form 4 — Scott C Taylor View Filing
form 4 Form 4 — Jonathan J Doyle View Filing
  • Trusted by 1M+ investors
  • Global coverage
  • Real-time market data
  • Independent & unbiased

Join thousands making smarter investment decisions.

Get started for free